Xandar Kardian

Overview
News
Next-gen Medical Devices?
Product stageSegments
Expansion
?
Monitoring devices
?

Xandar Kardian specializes in radar signal processing technology for presence detection and vital sign monitoring. Its flagship product, the XK300 Autonomous Health Monitoring Solution, is an FDA-approved, contact-free system capable of continuously measuring vital signs, such as resting heart rate, respiratory rate, body motion, and presence. The device utilizes ultra-wideband radar to detect micro-movements caused by heartbeats and breathing, even through obstacles like clothing and furniture, with an accuracy of 0.1 mm per nanosecond.

The company's patented sensors collect over 6,000 measurements daily, providing real-time, reliable data to healthcare providers. This technology offers early detection of potential medical events, including acute illnesses, cardiac or respiratory failure, and changes in chronic conditions, by monitoring subtle deviations from a patient's baseline vitals. Xandar Kardian's solution seamlessly integrates with existing monitoring systems or can replace them entirely, automating regular spot checks and reducing staff workload.

Its radar-based monitoring approach addresses staffing shortages by minimizing physical interactions, reducing infection risks, and reducing personal protective equipment costs. It also enables remote patient monitoring and hospital-at-home programs, which have grown 300% since 2021.

Key customers and partnerships

Xandar Kardian serves a diverse customer base across healthcare, correctional facilities, and smart building industries. In August 2023, Xandar Kardian reached a milestone of 50 deployments across healthcare facilities in the US. In July 2022, it partnered with TapestryHealth to implement its technology at nursing facilities. 

In August 2023, the company partnered with Caregility, a telehealth company, to integrate its radar technology into Caregility Cloud virtual care ecosystem. It also partnered with Reassurance Solutions in September 2023 to integrate its radar technology in correctional facilities. Other distribution partners include ERICOM, Telstra, TELUS, ORION, and cherrypicks.

HQ location:
1 King St. 48th floor Toronto, Ontario Toronto ON CAN
Founded year:
2017
Employees:
11-50
IPO status:
Private
Total funding:
USD 13.7 mn
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.